Cargando…
Radioembolization for the treatment of hepatocellular carcinoma
Transarterial radioembolization (TARE) with yttrium 90 ((90)Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass and resin microspheres with different physi...
Autor principal: | Kim, Hyo-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497664/ https://www.ncbi.nlm.nih.gov/pubmed/28494530 http://dx.doi.org/10.3350/cmh.2017.0004 |
Ejemplares similares
-
Radioembolization for hepatocellular carcinoma: what clinicians need to know
por: Choi, Jin Woo, et al.
Publicado: (2022) -
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016) -
Transarterial radioembolization for hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2016) -
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019) -
Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)